Medication-Assisted Treatment - Prescription Drug and Opioid Addiction (MAT-PDOA)

For program and eligibility questions:
Fred Bamfo
240.276.2423
 
Avery Gollinge
240.276.1156
 
MAT-PDOA-C@samhsa.hhs.gov

For financial and budget questions:
240.276.1400
NOFOBudget.CSAT@samhsa.hhs.gov

For grant review process and application status questions:
Hawa Kamara
240.276.1103
Hawa.Kamara@samhsa.hhs.gov

Grants.gov contact center:
800.518.4726
support@grants.gov
Self-service knowledge base

System for award management (SAM):
866.606.8220
Federal service desk

This opportunity, MAT-PDOA, offers grants to expand and enhance access to medications for opioid use disorder (MOUD); increase access to treatment and recovery for individuals with opioid use disorder (OUD); and decrease illicit opioid use, prescription opioid misuse, and overdose. Working with rural and resource-limited communities is listed as a required activity.

Awardees must:

• Offer Food and Drug Administration (FDA)-approved medications for OUD (methadone, buprenorphine, or naltrexone) combined with comprehensive psychosocial services, conduct clinical assessments using Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5-TR) criteria to create individualized treatment plans, and screen for co-occurring disorders
• Implement strategies to increase access for communities most impacted and least served, provide overdose prevention services including opioid overdose reversal medication (OORM) distribution and education
• Establish partnerships with community organizations to support treatment access, retention, and long-term recovery

Detailed lists of required and allowable activities are provided in the application instructions.

Eligible applicants:

• States and territories, including the District of Columbia
• Political subdivisions of states
• Tribes and tribal organizations
• Health facilities or programs operated by or in accordance with a contract or award with the Indian Health Service
• Other public or private nonprofit organizations, including faith-based organizations

Applicants from specific states that have been identified as having the highest age‑adjusted admission rates for treatment of opioid use disorders will receive priority points.

Award ceiling: $750,000 per year
Project period: Up to 5 years
Estimated number of awards: 91
Estimated total program funding: $68,250,000

Links to the full announcement, application instructions, and the online application process are available through grants.gov.